Meier Karen, Nanney Lillian B
S-2221 MCN Vanderbilt School of Medicine, Nashville, TN 37232, USA.
Expert Opin Emerg Drugs. 2006 Mar;11(1):23-37. doi: 10.1517/14728214.11.1.23.
Every year, millions of people experience burns, suffer from nonhealing wounds, or have acute wounds that become complicated by infection, dehiscence or problematic scarring. Effective wound treatment requires carefully considered interventions often requiring multiple clinic or hospital visits. The resulting costs of wound care are staggering, and more efficacious and cost-effective therapies are needed to decrease this burden. Unfortunately, the expenses and difficulties encountered in performing clinical trials have led to a relatively slow growth of new treatment options for the wound management. Research efforts attempting to examine wound pathophysiology have been hampered by the lack of an adequate chronic wound healing model, and the complexity of the wound healing cascade has limited attempts at pharmacological modification. As such, currently available wound healing therapies are only partially effective. Therefore, many new therapies are emerging that target various aspects of wound repair and the promise of new therapeutic interventions is on the immediate horizon.
每年,数以百万计的人遭受烧伤、患有难愈合伤口,或者有急性伤口并因感染、裂开或形成问题瘢痕而变得复杂。有效的伤口治疗需要经过仔细考虑的干预措施,这通常需要多次门诊或住院治疗。由此产生的伤口护理费用惊人,因此需要更有效且更具成本效益的疗法来减轻这一负担。不幸的是,进行临床试验所遇到的费用和困难导致伤口管理新治疗选择的增长相对缓慢。试图研究伤口病理生理学的研究工作因缺乏适当的慢性伤口愈合模型而受阻,并且伤口愈合级联反应的复杂性限制了药物改良的尝试。因此,目前可用的伤口愈合疗法仅部分有效。所以,许多针对伤口修复各个方面的新疗法正在涌现,新治疗干预措施的前景指日可待。